Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Summus Global
AddedFeb 17, 2024
UpdatedJun 18, 2026
Summus Global

Summus Global

Series B

Summus Global: A leading virtual platform connecting families to 4000+ top specialists globally.

HQ
Darien, CT, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Summus Global, founded with the mission to revolutionize access to medical expertise, offers a virtual specialist platform that connects individuals, families, and doctors with over 4,000 top specialists from 48 leading hospitals worldwide. The company aims to provide timely access to high-quality medical advice, thereby improving health outcomes. Summus Global's services cater to a broad range of health conditions, making it a valuable benefit for users seeking expert medical opinions swiftly and efficiently.

Notable figures associated with Summus Global include its network of specialists from prestigious hospitals. The company has garnered significant investment from leading venture capital firms, bolstering its growth and outreach. Key achievements include the rapid expansion of its specialist network and the successful implementation of its platform across various health conditions. Summus Global has had a profound impact on healthcare by enabling faster, more informed medical decisions, ultimately enhancing patient care and outcomes globally.

Summus Global - Similar Companies

AmplifyMD logo

AmplifyMD

amplifymd.com

Summer Health logo

Summer Health

summerhealth.com

ehumanlife logo

ehumanlife

Mederva Health logo

Mederva Health

medervahealth.com

MD Integrations logo

MD Integrations

mdintegrations.com

Docus logo

Docus

docus.ai

DocFlight logo

DocFlight

Health Global Connect logo

Health Global Connect

CirrusMD logo

CirrusMD

cirrusmd.com

MyTelemedicine logo

MyTelemedicine

mytelemedicine.com

VoyagerMed logo

VoyagerMed

voyagermed.com

RemoteDoc logo

RemoteDoc

Qapsula logo

Qapsula

qapsula.com

OpenLoop logo

OpenLoop

openloophealth.com

GuruMD logo

GuruMD

Summus Global - Quick Facts

Who are Summus Global's competitors?

Companies similar to Summus Global include AmplifyMD, Summer Health, ehumanlife and Mederva Health.

When was Summus Global founded?

Summus Global was founded in 2015.

Where is Summus Global's headquarters located?

Summus Global's headquarters is located in Darien, CT, US.

When was Summus Global's last funding round?

Summus Global's most recent funding round was for $19.5M (USD) in September 2023.

How much has Summus Global raised to-date?

As of Sep 13, 2023, Summus Global has raised a total of $56.8M (USD).

How many employees does Summus Global have?

Summus Global has 43 employees as of Feb 5, 2024.

Summus Global - Classification

Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Services
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 7 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software